This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics

Register by 26 June to save £1000

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
3-5 November 2026
RAIAmsterdam, Netherlands

Joanna Hemming Taylor, PhD
Associate Principal Scientist at AstraZeneca
Speaker

Profile

Joanna Hemming Taylor graduated with a MChem in Chemistry from the University of Manchester in 2009, followed by a PhD in biophysical and computational chemistry from University College London with an emphasis on characterisation of lipids and peptides at the air-liquid interface. In 2014 Joanna joined AstraZeneca and has worked as an analytical project lead on multiple early phase clinical projects, from small molecule therapeutics to larger synthetics such as peptides and drug-dendrimer conjugates. More recently, Joanna has been responsible for leading the analytical development and control strategy of siRNA projects within Early Chemical Development.

Agenda Sessions

  • Maintaining Diastereomeric Control in Phosphorothioate siRNAs: Integrated Analytical and Manufacturing Approaches for Reliable Clinical Development

    14:30